The potential of antibody-mediated immunity in the defence against biological weapons.
about
Rapid generation of an anthrax immunotherapeutic from goats using a novel non-toxic muramyl dipeptide adjuvant.Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.Therapeutic vaccine using a monoclonal antibody against a 70-kDa glycoprotein in mice infected with highly virulent Sporothrix schenckii and Sporothrix brasiliensis.
P2860
The potential of antibody-mediated immunity in the defence against biological weapons.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The potential of antibody-mediated immunity in the defence against biological weapons.
@ast
The potential of antibody-mediated immunity in the defence against biological weapons.
@en
type
label
The potential of antibody-mediated immunity in the defence against biological weapons.
@ast
The potential of antibody-mediated immunity in the defence against biological weapons.
@en
prefLabel
The potential of antibody-mediated immunity in the defence against biological weapons.
@ast
The potential of antibody-mediated immunity in the defence against biological weapons.
@en
P2860
P1476
The potential of antibody-mediated immunity in the defence against biological weapons.
@en
P2093
Arturo Casadevall
P2860
P304
P356
10.1517/14712598.5.10.1359
P407
P577
2005-10-01T00:00:00Z